Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Receptor Protein-Tyrosine Kinases

Known as: Receptor Protein Tyrosine Kinases, Tyrosine Kinase Growth Factor Receptor, Protein-Tyrosine Kinase Receptors 
A class of membrane receptors that contain protein tyrosine kinase activity. This enzymatic activity is integral to the function of the receptor as a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Abstractc-Met is a receptor tyrosine kinase belonging to the MET (MNNG HOS transforming gene) family, and is expressed on the… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Review
2018
Review
2018
The gene encoding the receptor-tyrosine kinase RET was first discovered more than three decades ago, and activating RET… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2018
Review
2018
Triple negative breast cancer (TNBC) is a complex and aggressive subtype of breast cancer which lacks oestrogen receptors… Expand
Is this relevant?
Review
2018
Review
2018
The invasion properties of glioblastoma hamper a radical surgery and are responsible for its recurrence. Understanding the… Expand
  • figure 2
  • figure 2
  • table 1
  • table 2
  • table 2
Is this relevant?
Review
2017
Review
2017
Anaplastic thyroid carcinoma (ATC) is a rare malignancy, accounting for 1–2% of all thyroid cancers. Although rare, ATC accounts… Expand
  • figure 1
  • figure 2
  • table 1
  • table 1
  • figure 3
Is this relevant?
Review
2017
Review
2017
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary tumor in the central nervous system. One of the… Expand
  • figure 1
  • table 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Pharmacological and cellular treatment of cancer is changing dramatically with benefits for patient outcome and comfort, but also… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2017
Review
2017
&NA; The hepatocyte growth factor receptor (MET) is a potential therapeutic target in a number of cancers, including NSCLC. In… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly upregulated in cancers such as in non… Expand
  • figure 1
Is this relevant?
Review
2017
Review
2017
The expanding spectrum of both established and candidate oncogenic driver mutations identified in non-small-cell lung cancer… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?